General Information of the Compound
| Compound ID |
CP0575330
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[[(1S,3aS,5aR,5bR,7aR,9R,11aR,11bR,13aR,13bR)-9-(ethylsulfamoyloxy)-5a,5b,8,8,11a-pentamethyl-1-propan-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carbonyl]amino]acetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H58N2O6S
|
||||||||||||||||||
| Molecular Weight |
622.913
|
||||||||||||||||||
| Canonical SMILES |
CCNS(=O)(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CC[C@]3(C)[C@@H]2CC[C@@H]2[C@H]4[C@@H](CC[C@@]4(CC[C@@]32C)C(=O)NCC(O)=O)C(C)C)C1(C)C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H58N2O6S/c1-9-36-43(40,41)42-26-14-15-31(6)24(30(26,4)5)13-16-33(8)25(31)11-10-23-28-22(21(2)3)12-17-34(28,19-18-32(23,33)7)29(39)35-20-27(37)38/h21-26,28,36H,9-20H2,1-8H3,(H,35,39)(H,37,38)/t22-,23+,24-,25+,26+,28+,31-,32+,33+,34-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CABMIWJXGLNJDA-BZRPJOEJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound